Published in Lab Law Weekly, January 19th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Akorn.
Report 1: Akorn, Inc., (AKN) announced that the U.S. Food and Drug Administration has granted tentative approval for Akorn's Abbreviated New Drug Application (ANDA) for Diclofenac Sodium Ophthalmic Solution 0.1% in 2.5 ml and 5 ml dropper bottles.
Final approval is expected upon expiry of patent protection for Voltaren Ophthalmic Solution 0.1% in October 2007.
Upon final approval, Akorn's Diclofenac Sodium Ophthalmic Solution 0.1% will be the generic equivalent of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly